Organisation
Department of Cardiovascular Sciences
Department
For more information about the research topics of the different research teams belonging to this department see: - Division for Cardiology - Division for Hypertension and Cardiovascular Revalidation - Division for Cardiovascular Developmental Physiology - Division for Molecular and Vascular Biology
The Department of Cardiovascular Sciences aims to increase knowledge in cardiovascular biology and diseases, to implement translation from bench to bedside and to improve patient care and cardiovascular health.
Sub-organisation(s)
1 - 10 of 12
Current researchers
1 - 4 of 4 results
- Werner Budts (Responsible)
- Alejandro Frangi (Member)
- Paul Holvoet (Member)
- Marcus Ingram (Member)
Projects
1 - 10 of 27
- Urinary PROteomics in Predicting HEart Transplantation outcomesFrom1 Oct 2016 → 31 Mar 2018Funding: H2020 - Frontier Research (ERC)
- Analysing and Modulating Apoptosis Sensitisation and Resistance in Cultured and Patient-Derived Cardiac Cells by Quantitative Biochemistry and Computational Systems Biology Implications to Cardiotoxicity and Differentiation.From1 Oct 2015 → 30 Sep 2016Funding: BOF - Concerted Research Project from 1994
- Do shared “omics” biomarkers reveal a systemic pathogenetic condition explaining association between left ventricular dysfunction and macrovascular disease?From4 May 2015 → 10 Dec 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quantitative approach to assess function and apoptosis changes in the H9C2 cardiomyocyte cell line following differentiation and Doxorubicin exposureFrom1 Dec 2014 → 8 Aug 2019Funding: BOF - doctoral mandates, BOF - Doctoral projects
- Role of Matrix Gla Protein and the Microcirculation in Differentiating Health from DiseaseFrom14 Nov 2014 → 26 Oct 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Adverse health outcomes in relation to blood pressure and genetic, epigenetic and environmental risk factorsFrom1 Oct 2014 → 26 Oct 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- "-omics" as tool to address the burden of non-communicable age-related disease in populations in epidemiological transitionFrom15 Mar 2014 → 15 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Heart OMics in AGEing: the prevalence of heart failure (HF).From19 Nov 2013 → 31 Jan 2019Funding: General Activities (Annex IV)
- Genetic and mtDNA contributions to early cardiovascular ageing and disease: a population studyFrom1 Oct 2013 → 28 Jun 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Regulation of endocardial cell plasticity during embryonic heart valve development and maturation through BMP SMADFrom1 Sep 2013 → 30 Sep 2018Funding: FWO fellowships
Publications
21 - 30 of 884
- Do level and variability of systolic blood pressure predict arterial properties or vice versa?(2014)
Authors: Yanping Liu, Yumei Gu, Lutgarde Thijs, Kei Asayama, Yu Jin, Lotte Jacobs, Tatiana Kouznetsova, Peter Verhamme, Jan A Staessen
Pages: 316 - 22 - Heritability and intrafamilial aggregation of arterial characteristics(2008)
Authors: Jan A Staessen, Tatiana Kouznetsova, Tim Nawrot, Lutgarde Thijs, Robert Fagard
Pages: 721 - 728 - Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies(2021)
Authors: Lutgarde Thijs, Zhenyu Zhang, Jesus Melgarejo, Jan A Staessen
Pages: 3071 - 3085 - Hypertension: Renal denervation-promising data from the DENERHTN trial(2015)
Authors: Wenyi Yang, Jan A Staessen
Pages: 258 - 60 - Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial (vol 374, pg 525, 2009)(2009)
Authors: P Verdecchia, Jan A Staessen, F Angeli
Pages: 880 - 880 - Association between left ventricular mass and telomere length in a population study(2010)
Authors: Tatiana Kouznetsova, Lutgarde Thijs, Yu Jin, Tom Richart, Jan A Staessen
Pages: 440 - 450 - Progress report on the first sub-Saharan trial of newer versus older antihypertensive drugs in native black patients(2012)
Authors: Augustine Odili, Lutgarde Thijs, Jan A Staessen
- PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population(2017)
Authors: Wenyi Yang, Thibault Petit, Nicholas Cauwenberghs, Zhenyu Zhang, Lutgarde Thijs, Benedetta Izzi, Christophe Vandenbriele, Fangfei Wei, Lotte Jacobs, Marc Hoylaerts, et al.
Pages: 45 - Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications(2010)
Authors: Lutgarde Thijs, Tom Richart, Jan A Staessen
Pages: 1060 - 1068 - A Woman With Treatment-Resistant Hypertension(2016)
Authors: Jan A Staessen
Pages: 243 - 250